logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Wilcrest Pharma Names a.J. Day, Pharm D, As Chief Executive Officer

Sep 06, 2024•over 1 year ago

Position

Chief Executive Officer

Company

Wilcrest Pharma

A.J. Day
HoustonPharmaceuticalBiotechnologyHealth Care

Description

Wilcrest Pharma, a newly formed, Houston-based 503B outsourcing facility specializing in producing antineoplastic medications and mitigating drug shortages, has named A.J. Day, PharmD, as its chief executive officer. Day, a dedicated advocate for compounded medicine and patient access, brings a long record of experience in regulatory affairs and compounding supply chain, which will be essential in driving the company's growth and advancing its product portfolio.

Company Information

Company

Wilcrest Pharma

Location

Houston, Texas, United States

About

Wilcrest Pharma is a newly formed, Houston-based 503B outsourcing facility focused on solving unmet needs in the pharmaceutical industry. The company will provide top-quality antineoplastic medications and address drug shortages to optimize patient health care for health systems, clinics, pharmacies and others. Wilcrest Pharma will officially open after the company has registered with the FDA and passed inspection to begin product sales.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months